Navigation Links
23andMe presents top 10 most interesting genetic findings of 2010
Date:1/12/2011

esearch paradigm, will continue to work together with its participants to make research discoveries and learn more about the information encoded in our genomes.

Eriksson N et al. (2010) Web-Based, Participant-Driven Studies Yield Novel Genetic Associations for Common Traits. PLoS Genetics. 6(6):e10000993.

"23andMe Publishes in PLoS Genetics, Validates New Research Paradigm." Jun 24, 2010. The Spittoon. http://spittoon.23andme.com/2010/06/24/plos-genetics-23andme/

"23andWe Research Update: Something Old and Something New." Dec 10, 2010. The Spittoon. http://spittoon.23andme.com/2010/12/10/23andwe-research-update-something-old-and-something-new/

"23andMe Launches Sarcoma Community." Apr 15, 2010. The Spittoon. http://spittoon.23andme.com/2010/04/15/23andme-launches-sarcoma-community/

"23andMe Launches Its First NIH Funded Study." Dec 16, 2010. The Spittoon. http://spittoon.23andme.com/2010/12/16/23andme-launches-first-national-institutes-of-health-funded-study/


'/>"/>

Contact: Jane E. Rubinstein
jrubinstein@rubenstein.com
212-843-8287
23andMe Inc.
Source:Eurekalert  

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology news :

1. 23andMe receives NIH funding to evaluate web-based research on the genetics of drug response
2. Colossal fossil: Museums new whale skeleton represents decades of research
3. UC doctoral student presents research at international conference
4. American Society of Agronomy presents 2010 Fellows
5. AMP presents at FDA meeting on regulating diagnostics
6. AAPS presents therapeutic protein drug interactions workshop
7. ASNTR meeting presents Sanberg Awards to Prof. Lin & Prof. Dunnett
8. Latino Theater Company Presents Dementia Starting April 29
9. Hormone sensitivity of breast stem cells presents drug target
10. NYU School of Medicine presents biomedical researchers Dart/NYU Biotechnology Achievement Awards
11. P&G Beauty & Grooming presents advancements in skin care at AAD Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
23andMe presents top 10 most interesting genetic findings of 2010
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
(Date:12/10/2014)... -- Valencell, a leader in performance biometric data sensor technology, ... its licensees for highly accurate, clinically validated biometric technology. ... from fitness and health sectors, but first responders/military and ... only as useful as the biometric data it delivers. ... long-term mass consumer adoption of wearable products," said Dr. ...
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... prestigious New England Journal of Medicine (NEJM) shows ... non-drug treatment for asthma, demonstrated an overall improvement ... Gerard Cox, respirologist at St. Joseph’s Healthcare Hamilton’s ... McMaster University, and Dr. John Miller, Division Head ...
... that it has added high-density genotyping on both ... of services. Stan Nelson, the principal investigator at ... its user-base of ~10,000 investigators across the world ... the scientific community." , The Consortium is ...
... provide cystic fibrosis (CF) patients with targeted treatment ... a French clinical trial published today in BMC ... sufferers with a rare genetic stop mutation responded ... Isabelle Sermet-Gaudelus of Faculté de Médicine Necker in ...
Cached Biology News:Groundbreaking Canadian asthma study 2NIH neuroscience microarray consortium launches high-throughput genotyping services 2
(Date:12/19/2014)... NEW YORK , Dec. 18, 2014 ... novel therapies for the treatment of chronic pain, announced ... held today. "This was a transformational year ... a promising future for our company," said Sergio ... past year, we have executed on key financial, human ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
(Date:12/17/2014)... Audacity, a leading California-based health and ... the Huntsworth Health Group, is proud to announce the ... her role, Gonzales will serve as Senior Vice President ... to welcome a talent of Jamie’s caliber to the ... “She is a proven healthcare innovation leader and brand ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
... of the ribosome, the cell,s protein-building machinery, sheds light ... life and suggests that differences in ribosomal structure between ... fossils" of the early evolution of protein synthesis. ... of Illinois, reveals that key regions of the ribosome ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ) ... year 2008 guidance. The Company has recorded adjustments,to ... sheet accounts,to record additional expenses related to stock-based ... since the adoption of Statement,of Financial Accounting Standard ...
... Brand Strength and Pediatric ... ... Pa., Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: BJGP; "BMP ... Ltd.,("Sunstone"), its wholly-owned subsidiary, has received a production,license from the ...
Cached Biology Technology:Molecular sleuths track evolution through the ribosome 2Molecular sleuths track evolution through the ribosome 3VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 2VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 3VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 4BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 2BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 3BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 4
...
Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
Permeabilization Solution, 5X...
PCR purification kit, 100 preps...
Biology Products: